Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

News & Analysis

China biotech company and industry news and analysis...

IASO Completes $108 Million C Round for Novel Cell Therapies

Cytovia Raises $45 Million for JV to Develop NK Products in China

Haisco Enters $140 Million Deal for Osteoarthritis Therapy

Alebund Pharma Raises $54.5 Million for Renal Disease Therapies

Harbour Bio to Start China Trials of CLTA-4/PD-1 Combo in Two Additional Cancers

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021